TNF Inhibitors Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017 - 2025

Aug 2018| TMR816A| Transparency

Report Highlights

Global TNF Inhibitors Market: Overview
This report on the TNF inhibitors market analyzes the current and future scenario of the global market. Rise in geriatric population, high prevalence of rheumatic diseases, and increase in patient preference for TNF inhibitors are major drivers of the global TNF inhibitors market.

The TNF inhibitors market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on drug, application, distribution channel, and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. Additionally, the section comprises competitive matrix and company profiles with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global TNF Inhibitors Market.

Global TNF Inhibitors Market: Key Segments
The overall TNF Inhibitors Market can be segmented based on drug, application, distribution channel, and geography. Furthermore, in terms of drug, the market can be divided into adalimumab, certolizumab, etanercept, golimumab, and infliximab. The adalimumab segment is likely to account for a leading share of the global TNF inhibitors market during the forecast period, owing to wide usage of adalimumab in moderate to severe disease conditions. Based on application the market can be classified into rheumatoid arthritis, psoriasis, inflammatory bowel disease, ankylosing spondylitis, and others. Based on distribution channel, the market can be segregated into hospital pharmacy, retail pharmacy, and online pharmacy. The market size and forecast for each of these segments have been provided for the period from 2017 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Global TNF Inhibitors Market: Regional Outlook
In terms of geography, the global TNF Inhibitors Market has been categorized into five major regions and the key countries in the respective region are: North America (U.S., Canada), Europe (U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, United Arab Emirates, Saudi Arabia, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2018 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report
The report also profiles major players in the global TNF inhibitors market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players operating in the global TNF inhibitors market include AbbVie, Inc., Janssen Biotech, Inc., UCB, Amgen, Inc., Pfizer, Inc., Samsung Bioepis, Biogen, Merck & Co., and Takeda Pharmaceutical Company.

The global TNF inhibitors market is segmented as given below:

Global TNF Inhibitors Market, by Drug, 2016–2026
Adalimumab
Certolizumab
Etanercept
Golimumab
Infliximab

Global TNF Inhibitors Market, by Application, 2016–2026
Rheumatoid Arthritis
Psoriasis
Inflammatory Bowel Disease
Ankylosing Spondylitis
Others

Global TNF Inhibitors Market, by Distribution Channel, 2016–2026
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Global TNF Inhibitors Market, by Geography, 2016–2026
North America
U.S.
Canada
Europe
Germany
U.K.
Italy
France
Spain
Rest of Europe
Asia Pacific
India
China
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
South Africa
UAE
Saudi Arabia
Rest of Middle East & Africa

  • Table 1 : Opportunity Map, by Drug
  • Table 2 : Opportunity Map, by Application
  • Table 3 : Opportunity Map, Distribution Channel
  • Table 4 : Global TNF Inhibitors Market Size (US$ Mn) Forecast, by Drug, 2016–2026
  • Table 5 : Global TNF Inhibitors Market Size (US$ Mn) Forecast, by Application, 2016–2026
  • Table 6 : Global TNF Inhibitors Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
  • Table 7 : Global TNF Inhibitors Market Size (US$ Mn) Forecast, by Region, 2016–2026
  • Table 8 : North America TNF Inhibitors Market Size (US$ Mn) Forecast, by Country, 2016–2026
  • Table 9 : North America TNF Inhibitors Market Size (US$ Mn) Forecast, by Drug, 2016–2026
  • Table 10 : North America TNF Inhibitors Market Size (US$ Mn) Forecast, by Application, 2016–2026
  • Table 11 : North America TNF Inhibitors Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
  • Table 12 : Europe TNF Inhibitors Market Size (US$ Mn) Forecast, by Country/Region, 2016–2026
  • Table 13 : Europe TNF Inhibitors Market Size (US$ Mn) Forecast, by Drug, 2016–2026
  • Table 14 : Europe TNF Inhibitors Market Size (US$ Mn) Forecast, by Application, 2016–2026
  • Table 15 : Europe TNF Inhibitors Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
  • Table 16 : Asia Pacific TNF Inhibitors Market Size (US$ Mn) Forecast, by Country/Region, 2016–2026
  • Table 17 : Asia Pacific TNF Inhibitors Market Size (US$ Mn) Forecast, by Drug, 2016–2026
  • Table 18 : Asia Pacific TNF Inhibitors Market Size (US$ Mn) Forecast, by Application, 2016–2026
  • Table 19 : Asia Pacific TNF Inhibitors Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
  • Table 20 : Latin America TNF Inhibitors Market Size (US$ Mn) Forecast, by Country/Region, 2016–2026
  • Table 21 : Latin America TNF Inhibitors Market Size (US$ Mn) Forecast, by Drug, 2016–2026
  • Table 22 : Latin America TNF Inhibitors Market Size (US$ Mn) Forecast, by Application, 2016–2026
  • Table 23 : Latin America TNF Inhibitors Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
  • Table 24 : Middle East & Africa TNF Inhibitors Market Size (US$ Mn) Forecast, by Country/Region, 2016–2026
  • Table 25 : Middle East & Africa TNF Inhibitors Market Size (US$ Mn) Forecast, by Drug, 2016–2026
  • Table 26 : Middle East & Africa TNF Inhibitors Market Size (US$ Mn) Forecast, by Application, 2016–2026
  • Table 27 : Middle East & Africa TNF Inhibitors Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
  • Figure 1 : Global TNF Inhibitors Market Size (US$ Mn), by Drug 2017 (A)
  • Figure 2 : Global TNF Inhibitors Market Revenue (%), by Application, 2017
  • Figure 3 : Global TNF Inhibitors Market Size (US$ Mn) Forecast, 2016–2026
  • Figure 4 : Market Value Share, by Region (2017)
  • Figure 5 : Market Value Share, by Drug (2017)
  • Figure 6 : Market Value Share, by Application (2017)
  • Figure 7 : Market Value Share, by Distribution Channel (2017)
  • Figure 8 : Global TNF Inhibitors Market Value Share Analysis, by Drug, 2016 and 2026
  • Figure 9 : Global TNF inhibitors Market Attractiveness, by Drug, 2018–2026
  • Figure 10 : Global TNF Inhibitors Market Value (US$ Mn) and Y-o-Y Growth, by Adalimumab, 2016–2026
  • Figure 11 : Global TNF Inhibitors Market Value (US$ Mn) and Y-o-Y Growth, by Certolizumab, 2016–2026
  • Figure 12 : Global TNF Inhibitors Market Value (US$ Mn) and Y-o-Y Growth, by Etanercept, 2016–2026
  • Figure 13 : Global TNF Inhibitors Market Value (US$ Mn) and Y-o-Y Growth, by Golimumab, 2016–2026
  • Figure 14 : Global TNF Inhibitors Market Value (US$ Mn) and Y-o-Y Growth, by Infliximab, 2016–2026
  • Figure 15 : Global TNF Inhibitors Market Value Share Analysis, by Application, 2017 and 2026
  • Figure 16 : Global TNF Inhibitors Market Attractiveness, by Application, 2018–2026
  • Figure 17 : Global TNF Inhibitors Market Value (US$ Mn) and Y-o-Y Growth, by Rheumatoid Arthritis, 2016–2026
  • Figure 18 : Global TNF Inhibitors Market Value (US$ Mn) and Y-o-Y Growth, by Psoriasis, 2016–2026
  • Figure 19 : Global TNF Inhibitors Market Value (US$ Mn) and Y-o-Y Growth, by Inflammatory Bowel Disease, 2016–2026
  • Figure 20 : Global TNF Inhibitors Market Value (US$ Mn) and Y-o-Y Growth, by Ankylosing Spondylitis, 2016–2026
  • Figure 21 : Global TNF Inhibitors Market Value (US$ Mn) and Y-o-Y Growth, by Others, 2016–2026
  • Figure 22 : Global TNF Inhibitors Market Value Share, by Distribution Channel, 2017 and 2026
  • Figure 23 : Global TNF Inhibitors Market Attractiveness, by Distribution Channel, 2018–2026
  • Figure 24 : Global TNF Inhibitors Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospital Pharmacy, 2016–2026
  • Figure 25 : Global TNF Inhibitors Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Retail Pharmacy, 2016–2026
  • Figure 26 : Global TNF Inhibitors Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Online Pharmacy, 2016-2026
  • Figure 27 : Global TNF Inhibitors Market Value Share, by Region, 2016 and 2025
  • Figure 28 : Global TNF Inhibitors Market Attractiveness, by Region, 2018–2026
  • Figure 29 : North America TNF Inhibitors Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2025
  • Figure 30 : North America TNF Inhibitors Market Value Share Analysis, by Country, 2017 and 2026
  • Figure 31 : North America TNF Inhibitors Market Attractiveness Analysis, by Country, 2018–2026
  • Figure 32 : North America TNF Inhibitors Market Value Share Analysis, by Drug, 2017 and 2026
  • Figure 33 : North America TNF Inhibitors Market Value Share Analysis, by Application, 2017 and 2026
  • Figure 34 : North America TNF Inhibitors Market Value Share Analysis, by Distribution Channel, 2017 and 2026
  • Figure 35 : North America TNF Inhibitors Market Attractiveness Analysis, by Drug, 2018–2026
  • Figure 36 : North America TNF Inhibitors Market Attractiveness Analysis, by Application, 2018–2026
  • Figure 37 : North America TNF Inhibitors Market Attractiveness Analysis, by Distribution Channel, 2018–2026
  • Figure 38 : Europe TNF Inhibitors Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2025
  • Figure 39 : Europe TNF Inhibitors Market Value Share Analysis, by Country, 2017 and 2026
  • Figure 40 : Europe TNF Inhibitors Market Attractiveness Analysis, by Country, 2018-2026
  • Figure 41 : Europe TNF Inhibitors Market Value Share Analysis, by Drug, 2017 and 2026
  • Figure 42 : Europe TNF Inhibitors Market Value Share Analysis, by Application, 2017 and 2026
  • Figure 43 : Europe TNF Inhibitors Market Value Share Analysis, by Distribution Channel, 2017 and 2026
  • Figure 44 : Europe TNF Inhibitors Market Attractiveness Analysis, by Drug, 2018–2026
  • Figure 45 : Europe TNF Inhibitors Market Attractiveness Analysis, by Application, 2018–2026
  • Figure 46 : Europe TNF Inhibitors Market Attractiveness Analysis, by Distribution Channel, 2018–2026
  • Figure 47 : Asia Pacific TNF Inhibitors Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2018–2026
  • Figure 48 : Asia Pacific TNF Inhibitors Market Value Share Analysis, by Country, 2017 and 2026
  • Figure 49 : Asia Pacific TNF Inhibitors Market Attractiveness Analysis, by Country/Sub-region, 2018?2026
  • Figure 50 : Asia Pacific TNF Inhibitors Market Value Share Analysis, by Drug, 2017 and 2026
  • Figure 51 : Asia Pacific TNF Inhibitors Market Value Share Analysis, by Application, 2017 and 2026
  • Figure 52 : Asia Pacific TNF Inhibitors Market Value Share Analysis, by Distribution Channel, 2017 and 2026
  • Figure 53 : Asia Pacific TNF Inhibitors Market Attractiveness Analysis, by Drug, 2018–2026
  • Figure 54 : Asia Pacific TNF Inhibitors Market Attractiveness Analysis, by Application, 2018–2026
  • Figure 55 : Asia Pacific TNF Inhibitors Market Attractiveness Analysis, by Distribution Channel, 2018–2026
  • Figure 56 : Latin America TNF Inhibitors Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2018–2026
  • Figure 57 : Latin America TNF Inhibitors Market Value Share Analysis, by Country, 2017 and 2026
  • Figure 58 : Latin America TNF Inhibitors Market Attractiveness Analysis, by Country/Sub-region, 2018?2026
  • Figure 59 : Latin America TNF Inhibitors Market Value Share Analysis, by Drug, 2017 and 2026
  • Figure 60 : Latin America TNF Inhibitors Market Value Share Analysis, by Application, 2017 and 2026
  • Figure 61 : Latin America TNF Inhibitors Market Value Share Analysis, by Distribution Channel, 2017 and 2026
  • Figure 62 : Latin America TNF Inhibitors Market Attractiveness Analysis, by Drug, 2018–2026
  • Figure 63 : Latin America TNF Inhibitors Market Attractiveness Analysis, by Application, 2018–2026
  • Figure 64 : Latin America TNF Inhibitors Market Attractiveness Analysis, by Distribution Channel, 2018–2026
  • Figure 65 : Middle East & Africa TNF Inhibitors Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2018– 2026
  • Figure 66 : Middle East & Africa TNF Inhibitors Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
  • Figure 67 : Middle East & Africa TNF Inhibitors Market Attractiveness Analysis, by Country/Sub-region, 2018?2026
  • Figure 68 : Middle East & Africa TNF Inhibitors Market Value Share Analysis, by Drug, 2017 and 2026
  • Figure 69 : Middle East & Africa TNF Inhibitors Market Value Share Analysis, by Application, 2017 and 2026
  • Figure 70 : Middle East & Africa TNF Inhibitors Market Value Share Analysis, by Distribution Channel, 2017 and 2026
  • Figure 71 : Middle East & Africa TNF Inhibitors Market Attractiveness Analysis, by Drug, 2018–2026
  • Figure 72 : Middle East & Africa TNF Inhibitors Market Attractiveness Analysis, by Application, 2018–2026
  • Figure 73 : Middle East & Africa TNF Inhibitors Market Attractiveness Analysis, by Distribution Channel, 2018–2026
  • Figure 74 : Global TNF Inhibitors Market Share Analysis, by Company (2017)

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report